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Background: Swietenia macrophylla King (Meliaceae) is used to treat diabetes mellitus in Malaysia. This study aims
to evaluate the anti-hyperglycaemic potential of petroleum ether (PE), chloroform (CE) and methanol (ME) extracts
of S. macrophylla seeds, in normoglycaemic and streptozotocin (STZ)-induced diabetic rats.
Methods: Following treatment of normoglycaemic rats with S. macrophylla seed extracts, hypoglycaemic and
intraperitoneal glucose tolerance tests (IPGTT) were performed, and blood glucose concentrations were measured.
Similarly, glucose concentrations were measured after 1 and 14 days of extract treatment of STZ-induced diabetic
rats. Glucose absorption by isolated everted intestine and glucose uptake by isolated abdominal muscle were
tested after treatment with seed extracts. Gas chromatography mass spectrometry (GC-MS) analysis was performed
on PE of S. macrophylla seeds to identify the compounds responsible for its activity.
Results: None of the extracts had a significant effect on the blood glucose levels of 60 randomly selected
normoglycaemic (normal) and diabetic rats undergoing hypoglycaemic tests. PE, however, significantly reduced
blood glucose levels in 30 randomly selected normoglycaemic rats undergoing IPGTT tests 30–120 minutes after
glucose administration. Repeated doses of 1000 mg/kg and 500 mg/kg PE to STZ-induced diabetic rats for 14 days
did not reduce blood glucose levels significantly. PE did not significantly reduced the intestinal absorption of
glucose, but significantly increased glucose uptake by abdominal muscle in the absence or presence of insulin.
GC-MS analysis indicated that diterpenes, triterpenoids, fatty acid methyl esters, aldehydes and phytosterols may be
responsible for the glucose lowering effects of PE.
Conclusion: PE extracts of S. macrophylla seeds showed anti-hyperglycaemic activity on IPGTTs . GC-MS analysis on
the PE revealed that several compounds, including fucosterol and β-sitosterol, may be responsible for these
anti-hyperglycaemic properties.* Correspondence: mal_roteiro85@yahoo.com.my
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Diabetes mellitus is a disease in which the homeostasis
of carbohydrate, protein and lipid metabolism is improp-
erly regulated by insulin, resulting in elevated fasting
and post-prandial blood glucose concentrations. Chronic
hyperglycaemia causes many complications, including
nephropathy, retinopathy, neuropathy, and macro-
vascular and microvascular damage [1]. Its symptoms
include polyurea, polydipsia, polyphagia, weight loss,
fatigue, cramps, constipation and blurred vision. In
2004, the World Health Organization (WHO) estimated
that the prevalence of diabetes worldwide will increase
from 171 million in 2000 to 366 million in 2030 [2]. The
Malaysia Diabetes Association has estimated that ap-
proximately 1.7 million people are currently affected and
that further industrialisation and modernization may
result in a double of this number by 2030 [3].
Generally, patients with diabetes mellitus are treated
with oral hypoglycaemic agents (OHA) and insulin [4].
These drugs, however, are not suitable for use during
pregnancy and can produce serious side effects [5-8].
The use of medicinal plants to treat diabetes mellitus is
popular, as herbal drugs are generally regarded as free of
toxic effects [9]. Therefore, the search for more effective
and safer herbal anti-diabetic agents has become an area
of active research.
Swietenia macrophylla King (Meliaceae), commonly
known as big leaf mahogany (vernacular) and ‘skyfruit’
(local), is used to treat diabetes and high blood pressure
in Malaysia [10]. S. macrophylla seeds have been re-
ported to have anti-inflammatory, anti-mutagenic and
anti-tumor activities [11] and to be effective against
diabetes in rats [12]. In Chinese pharmacology and other
traditional medicines, this plant has antipyretic, anti-
fungal, and antihypertensive properties, pharmacological
effects obtained from dried seeds, finely ground to
powder [13].
Traditionally, raw seeds of S. macrophylla are chewed
to treat diabetes. In Malaysia, these seeds are chewed or
pounded and swallowed to treat high blood pressure
[10] and in India, they are used to treat diabetes and
hypertension [14]. We therefore elected to extract the
seeds using the maceration method rather than the
soxhlet method since the former method exposes the
seeds to lower temperatures. The soxhlet method was
avoided since prolonged heating may degrade thermo-
labile compounds [15].
This study was designed to investigate S. macrophylla
seed extracts in different in vivo and in vitro diabetic
models in order to evaluate their anti-hyperglycaemic
properties and to elucidate the possible mechanism
underlying these properties. Compounds possibly re-
sponsible for these activities were determined by GC-
MS analysis.Materials and methods
Chemicals and reagents
All chemicals and solvents were of analytical grade.
Petroleum-ether (60–80°C), chloroform and methanol were
purchased from Merck (Darmstadt, Germany). Strep-
tozotocin (STZ) was purchased from Sigma Chemicals
(St. Louis, MO, USA).
Plant materials
The fruit seeds of S. macrophylla were collected from
the area of Jitra, Malaysia, between December 2008 and
February 2009 and identified by Mr. Vellosamy
Shunmugam, a plant taxonomist from the School of
Biological Sciences, Universiti Sains Malaysia (USM). A
voucher specimen was deposited (11239) in the herbar-
ium of the School of Biological Sciences, USM.
Extraction of plant material
The fruits were peeled to get the seeds. The seeds were
dried in an oven at 45°C for one week, then ground to a
coarse powder in an electrical grinder, weighed and
stored in a dry place. The dried powder (2.2 kg) was
continuously extracted by the maceration method [16]
using petroleum ether (60–80°C), chloroform (CE) or
methanol (ME), three times each.
The solvents from each extract were removed using a
rotary evaporator, and the extracts were stored at −70°C
for 48 hours, and freeze dried under vacuum at −40°C
for 24 h using a freeze-dryer (Labconco Corporation,
Denmark). Each dried extract was kept in tightly covered
glass bottles and stored at 4°C. The yields of each extract
are shown in Table 1.
Experimental animals
Randomly selected male Sprague–Dawley rats (200–250 g;
12–16 weeks of age) were obtained from the animal house
of the School of Pharmaceutical Sciences, USM and kept
under standard conditions of 12 h: 12 h light and dark in
polypropylene cages and fed a standard laboratory diet and
water ad libitum. All experiments included six rats per
group, and all experiments adhered to the principles of
Laboratory Animal Care and the protocols of the Animal
Ethics Committee of USM (USM/PPSF/50 (081) Jld 2.
Hypoglycaemic test in normal rats
Thirty randomly selected normal male Sprague–Dawley
rats weighing 200–250 g were arbitrarily divided into
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Group 1 (negative control) rats were treated with 4%
Tween 80 (10 mL/kg), group 2 (positive control) rats
with glibenclamide (10 mg/kg), group 3 rats with 1000
mg/kg petroleum ether (PE), group 4 with 1000 mg/kg
CE, and group 5 with 1000 mg/kg ME, all by gavage.
Blood samples were drawn from each rat’s tail vein at
just prior to treatment and 1, 2, 3, 5 and 7 h after
treatment, and blood glucose concentrations were deter-
mined using an Accu-Check Advantage II Clinical
Glucose meter (Roche, USA).Intraperitoneal glucose tolerance test (IPGTT) in normal rats
Thirty rats were divided into five groups of 6 rats each.
After an overnight (16 h fast), the rats were treated as
described above. Sixty minutes later, each rat was admi-
nistered glucose (500 mg/kg b.w.) by intraperitoneal
(i.p.) injection. Blood samples were drawn from each
rat’s tail vein at −60 min (just before gavage), 0 min
(before glucose load), and 15, 30, 45, 60, 90 and 120 min
after glucose administration. Blood glucose concentra-
tions were determined as above.Induction of diabetes in normal rats
Diabetes was induced in overnight fasted (16 h)
Sprague–Dawley rats by a single i.p. injection of 60 mg/kg
streptozotocin (STZ) dissolved in normal saline (0.9%
NaCl, pH 4.5) just prior to administration [17]. Hypergly-
caemia was confirmed by elevations in blood glucose
concentrations 72 h later and by polyurea and loss of bodyFigure 1 Effect of orally administered S. macrophylla seed extracts (1
represents the mean ± SD for six rats. * P < 0.05 compared with negative cweight. Rats with fasting blood glucose (FBG) concentra-
tions above 15 mmol/L were considered diabetic.
Hypoglycaemic tests in diabetic rats
Thirty diabetic rats weighing 170–220 g were arbitrarily
divided into five groups of 6 rats each, fasted overnight,
and treated as above. Blood samples were drawn at 0 h
(just before gavage), and 1, 2, 3, 5 and 7 h after treat-
ment. Blood glucose concentration was measured as
above.
Treatment of diabetic rats for 14 days
Twenty male rats with STZ-induced diabetes were
randomly divided into four groups of 5 rats each. Group
1 (negative control) rats were treated with 4% Tween 80
(10 mL/kg), group 2 (positive control) rats with metfor-
min (500 mg/kg), group 3 rats with 1000 mg/kg PE and
group 4 rats with 500 mg/kg PE, all by gavage, twice
daily (at 9 a.m. and 9 p.m.) for 14 days. Body weight was
measured every two days. Fasting blood glucose levels
and body weight of the rats were determined before and
after the 14-day treatment period.
In vitro glucose absorption by isolated everted intestine
Although none of the three extracts of S. macrophylla
seeds, PE, CE, and ME, had any hypoglycaemic activity
in normal rats (Figure 1), PE showed the highest anti-
hyperglycaemic activity in the IPGTT test (Figure 2).
Therefore, the anti-hyperglycaemic properties were
further investigated.g/kg b.w.) on hypoglycaemic tests in normal rats. Each value
ontrol rats.
Figure 2 Effect of orally administered S. macrophylla seed extracts (1 g/kg b.w.) on IPGTT results in normal rats. Each value represents
the mean ± SD for six rats. * P < 0.05, ** P < 0.005 compared with negative control rats.
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weighing 250–300 g were sacrificed by a blow to the
head, followed by cervical dislocation and dissection of
their abdominal walls. The effect of PE on glucose
absorption by the rat intestine was assessed as described
[18]. After the abdomen was opened, the small intestine
was excised, placed in oxygenated Tyrode’s solution
(342 mM NaCl, 6.7 mM KCl, 5.9 mM CaCl2.2H2O,
5.3 mM MgCl2, 59.5 mM NaHCO3, 2.08 mM
NaH2PO2, 5.5 mM glucose) and rinsed with the same so-
lution to remove intestinal contents. The jejunum (24- to
50-cm from the pylorus) was identified and isolated fromFigure 3 Effect of orally administered S. macrophylla seeds extracts (1
Each value represents the mean ± SD for six rats. ** P < 0.001 compared wthe small intestine, everted and cut into 5-cm long pieces.
One end of each piece was tied with a cotton thread, and
filled with 1 mL of Tyrode’s solution, and the other end
was tied, forming a sac. Sacs were incubated in 15 mL
Tyrode’s solution for 90 min in the presence of 1 and
2 mg/mL PE, 1 and 2 mg/mL acarbose, an α-glucosidase
inhibitor as positive controls, or Tyrode’s solution alone as
the negative control. At the end of the incubation period,
the glucose concentrations inside the sacs and in the
incubation media were determined by the Statfax machine
(model 1906, 45 Watts, Awareness Tech, Inc. Palm City,
FL, USA) so that the amount of glucose uptake could beg/kg b.w) on hypoglycaemic tests in STZ-induced diabetic rats.
ith negative control rats.
Figure 4 Effects on body weight (A) and blood glucose
concentration (B) after 14 days of oral administration of
10 mL/kg 4% Tween 80 (negative control), 500 mg/kg
metformin (positive control), and 500 mg/kg and 1000 mg/kg
PE to diabetic rats. Each value represents the mean ± SD for five
rats. **P < 0.01 compared with negative control rats.
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tion or glucose uptake per g tissue weight.
In vitro glucose uptake by isolated abdominal muscles
Glucose uptake by rat abdominal muscles was assessed
as described [19], with some modifications. Male
Sprague–Dawley rats weighing 200-250 g were sacri-
ficed as above and skinned at the abdomen to expose
their abdominal muscles. The rectus abdominus was
removed from the abdominal muscle, and the clean
muscle was transferred to Krebs solution aerated with
95% O2. Both sides of the abdominal muscles were cut
into small squares weighing approximately 150–300 mg,
and kept in Krebs-Ringer bicarbonate buffer (KRB;
118 mM NaCl, 5 mM KCl, 1.28 mM CaCl2, 1.2 mM
KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3) for 10 min
at 37°C in the presence of 95% O2 and 5% CO2. The
solution was replaced by Krebs solution containing
11.1 mM glucose and samples were collected for base-
line readings. Tissue samples were incubated with 1
and 2 mg/mL PE or 1 mg/mL metformin in the pres-
ence or absence of insulin (1 I.U./mL). The solutions
were aerated for 5 min and incubated for 30 min at
37°C while shaking at 96 rpm. Muscle weight was
measured to determine the amount of glucose uptake
per gram, and glucose concentration was measured
using the Statfax machine.
Gas chromatography–mass spectrometry (GC-MS) analysis
GC-MS analysis of the PE extract was performed using
an Agilent 6890 gas chromatography instrument coupled
to an Agilent 5973 mass spectrometer and Agilent
Chemstation software (Agilent Technologies, Palo Alto,
CA, USA). Compounds were separated on a HP-5MS,
30 m × 0.25 mm i.d. capillary column coated with
0.25-μm film. The oven temperature was held at 70°C
for 2 min and increased to 285°C isothermally over
20 min. Helium was the carrier gas at a flow rate of 1.2
mL/min. The injector and detector temperatures were
280°C and 250°C, respectively. The parameters of the
HP 5973 mass detector were: ion mass/charge ratio, 20–
500 m/z; scan mode and ionisation energy of 70 eV.
Sample components were identified by matching their
mass spectra with those recorded in the NIST/Wiley
Library and comparing the literature data with GC
retention indices [20].
Statistical analysis
All data are expressed as mean ± standard deviation
(SD), and all statistical analyses were performed using
SPSS ver 11.5 software (SPSS Inc., Chicago, IL). Mean
between group differences were analysed by one-way
ANOVA at an α-value (probability level) P < 0.05
followed by Dunnett t-test as a post-hoc test, except forthe 14-day treatment where the means differences
between pre and post-treatment parameters were
analysed by paired t-tests and considered significant at
P < 0.05.
Results
Hypoglycaemic test in normal rats
Oral administration of 1000 mg/kg of the three
S. macrophylla seed extracts to normal rats, had no
effect on fasting blood glucose concentrations, compared
with control rats, whereas the positive control, 10 mg/kg
glibenclamide, significantly reduced fasting blood glu-
cose concentrations (Figure 1).
IPGTT in normal rats
Figure 2 shows that the blood glucose levels in each
group increased after i.p. loading of 500 mg/kg glucose.
Although ME had no effect on blood glucose concentra-
tions, PE significantly reduced blood glucose at 30–120
min after glucose loading. Similarly, the positive control,
Figure 5 Effects of PE and acarbose, at concentrations of 1 and
2 mg/mL, on glucose absorption by everted intestine. Each
value represents the mean ± SD of 8 samples. *** P < 0.01
compared with the control group.
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concentrations.
Hypoglycaemic test in diabetic rats
Oral administration of 1000 mg/kg PE, CE and ME to
diabetic rats (Figure 3) did not significantly affect
their fasting blood glucose concentrations compared
with control rats. Treatment with 5 IU/kg insulin,
however, significantly reduced fasting blood glucose
concentrations.
Effects of treatment for 14 days
Treatment with 4% Tween 80 for 14 days significantly
reduced the body weight (P = 0.008) of rats with STZ-
induced diabetic rats, as did 14 days of treatment with
500 mg/kg metformin (P = 0.006) or 500 (P = 0.008) or
1000 (P = 0.006) mg/kg PE (Figure 4A).Figure 6 Effects of PE (1 and 2 mg/mL) and metformin (1 mg/mL) on
presence or absence of insulin. Each value represents the mean ± SD of
# P< 0.05 compared with control in the absence of insulin.Treatment with 4% Tween 80 or 500 or 1000 mg/kg
PE for 14 days had no effect on blood glucose
concentrations, whereas 500 mg/kg metformin sig-
nificantly (P = 0.007) reduced blood glucose levels
(Figure 4B).
In vitro experiments
Effect of PE on glucose absorption by isolated everted
intestine
Acarbose (1 mg/mL) and PE (1 and 2 mg/mL) did not
significantly inhibit glucose absorption through everted
intestinal sacs, whereas 2 mg/mL acarbose had a signifi-
cant (P = 0.007) effect (Figure 5).
Effect of PE on glucose uptake by isolated abdominal
muscle
In the absence of insulin, 1 mg/mL metformin (P =
0.042) and 1 (P = 0.034) and 2 (P = 0.048) mg/mL PE
significantly increased glucose uptake by abdominal
muscles (Figure 6). These effects were further elevated
in the presence of 1 IU/mL insulin, with 1 mg/mL met-
formin (P = 0.003) and 1 (P = 0.009) and 2 (P = 0.005)
mg/mL PE significantly increasing glucose uptake com-
pared with control.
GC-MS analysis of PE
GC-MS analysis identified the constituents of PE
(Table 2) as hexadecanoic acid methyl ester, n-
hexadecanoic acid, 9-octadecenoic acid (Z)-methyl ester,
linoleic acid, gamma-tocopherol, fucosterol and β-
sitosterol. The major constituents were linoleic acid
(72.46%), n-hexadecanoic acid (16.44%), 9-octadecenoicglucose uptake by isolated rat abdominal muscles in the
8 samples. * P< 0.05 compared with control in the presence of insulin;
Figure 8 The chemical structure of fucosterol.


















16.44 Gamma-tocopherol 0.38 C28H48O2
20.01 Fucosterol 2.45 C29H48O
20.20 β- sitosterol 0.41 C29H50O
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[Figure 7] and fucosterol (2.45%) [Figure 8].
Discussions
Diabetes mellitus is a metabolic disorder involving oxi-
dative stress, which induces insulin resistance in the
peripheral tissues and impairs insulin secretion by
pancreatic β-cells [21-23]. A large number of hypo-
glycaemic/antidiabetic plants and herbs have been stu-
died by modern methods and are starting to be
introduced into modern therapy.
We utilized the IPGTT rather than the oral glucose tol-
erance test (OGTT) to investigate the anti-hyperglycaemic
properties of S. macrophylla seed extracts. The OGTT can
yield false positive results due to the sticky or viscous
nature of plant extracts. These extracts may interfere with
glucose absorption in the gastrointestinal tract when
glucose is loaded one hour after administration of the
extract. We therefore decided to deliver the extract/drug
orally but to load glucose intraperitoneally one hour.
We found that PE, at a dose of 1000 mg/kg b.w.,
reduced blood glucose concentration in normal rats,
suggesting that PE has anti-hyperglycaemic properties,
as well as significantly suppressing the increase in blood
glucose levels following glucose loading. The anti-Figure 7 The chemical structure of β-sitosterol.hyperglycaemic potential of PE was further evaluated
using isolated everted jejunal sacs and isolated abdom-
inal muscles. Blood glucose concentrations in everted
jejunal sacs are reduced by inhibition of glucose absorp-
tion, for example by α-glucosidase inhibitors such as
acarbose [24]. We found that 2 mg/mL acarbose but not
1.0 or 2.0 mg/mL PE significantly inhibited intestinal
glucose absorption. By contrast, both concentrations of
PE significantly increased glucose uptake by isolated
abdominal muscle in the absence or presence of insulin.
Therefore, although PE may not inhibit glucose absorp-
tion by the rat small intestine, it may promote glucose
utilisation by muscle tissue.
PE may significantly reduce fasting blood glucose con-
centration in normal rats by other mechanisms of action,
including the stimulation of the residual pancreatic
mechanism or by increasing the peripheral utilisation of
glucose [25]. Moreover, the anti-hyperglycaemic pro-
perties of PE may be associated with more than one
mechanism, including the modulation of insulin secre-
tion or action, extrapancreatic and pancreatic effects
[26-28], antioxidant activity [29], enhancement of β-cell
glucose metabolism or activation of enzyme systems that
generate cyclic AMP or phospholipid derived messen-
gers [30].
STZ-induced hyperglycaemia is a useful experimental
model for studying the activity of hypoglycaemic agents
[31]. STZ selectively destroys pancreatic insulin secret-
ing β-cells. Using this model, we assessed whether 14
days of treatment with PE could induce significant
recovery of these diabetic rats. We found that neither
500 nor 1000 mg/kg PE twice daily for 14 days signifi-
cantly affected blood glucose concentrations in these
diabetic rats.
GC-MS analysis of PE showed the presence of diter-
pene and triterpenoids, fatty acid methyl esters,
aldehydes and phytosterols. The high concentrations of
fatty acids and sterol compounds may be responsible for
the antihyperglycaemic activity of PE. In addition,
significantly reduced blood glucose concentrations have
been reported in rats fed fucosterol [32], suggesting that
Pelvetia siliquosa fucosterol may have a significant
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fucosterol may also be important in the anti-
hyperglycaemic effects of PE of S. macrophylla seeds.
Conclusion
PE from S. macrophylla seeds was found to possess anti-
hyperglycaemic activity on the IPGTT. GC-MS analysis
of the PE revealed several compounds, including
fucosterol and β-sitosterol, that may be responsible for
the anti-hyperglycaemic properties of this extract.
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